Pericarditis Market Overview:
“Pericaditis Market: By Type (Acute
Pericarditis, Chronic Pericarditis and Recurrent Pericarditis), By Diagnosis
and Treatment [Diagnosis (Electrocardiogram (ECG), Echocardiogram, Computerized
Tomography (CT), and X-Ray), Treatment (Medication and Surgical Treatment)], By
End User (Hospitals and Clinics, Medical Institutes, Research Organizations and
Others) and By Region - Global Forecast Till 2023”
According to Market Research Future
(MRFR)’s analysis, the global pericarditis
market is expected to touch a valuation of USD 2,741.39 Mn by the end
of 2023 up from USD 1,750.38 Mn in 2017. The report also reveals that the
market is predicted to thrive at a CAGR of 7.96% during the forecast period
2018 to 2023. Cardiovascular diseases are widely prevalent across the world,
and the patient population is presumed to increase further over the next couple
of years. A major proportion of these patients are likely to develop symptoms
of pericarditis. It has been projected that the pericarditis market will
witness an influx of patient population, thus, generating demand for advanced
drugs and treatments.
The advent of advanced minimally invasive
surgeries has revolutionized the pericarditis market. It has encouraged
patients for early diagnosis and treatment. Also, the introduction of
robot-assisted cardiac surgeries has gained considerable popularity among the
patients due to its assurance of precision. This, in turn, is likely to have a
positive influence on the proliferation of the pericarditis market.
The trouble-free settlement of
reimbursements is anticipated to favor the growth of the market through the
assessment period. On the flip side, the risk of infections owing to the
insertion of catheters in the body remains an impediment to the market growth.
Furthermore, the continuous dosages of anti-inflammatory drugs used for the
treatment of pericarditis can lead to side-effects. It is predicted to hinder
the expansion of the pericarditis market in the foreseeable future.
Global Market for Pericarditis – Segmental Analysis:
This MRFR report offers a comprehensive
segmental assessment of the global pericarditis market based on type, diagnosis
& treatment, and end-user. By type, the market is segmented into acute
pericarditis, chronic pericarditis, and recurrent pericarditis. Among these,
the acute pericarditis market is presumed to account for a major share of the
market in the upcoming years. The valuation of the segment is forecasted to
grow from USD 888.91 Mn in 2017 to USD 1,365.94 Mn in 2023. Meanwhile, the
recurrent pericarditis segment is expected to expand at a comparatively higher
CAGR during the projection period.
By diagnosis & treatment, the
pericarditis market has been segmented into diagnosis and treatment. The
diagnosis segment has been further sub-segmented into electrocardiogram,
echocardiogram, CT, X-ray, and others. The treatment segment is sub-segmented
into medication, surgical treatment, and others. Among these, the treatment
segment is projected to attract a larger customer base across the review
period. However, the diagnosis segment is anticipated to strike a relatively
higher CAGR of 8.32% over 2023.
By end-user, the global pericarditis
market has been segmented into hospitals and clinics, medical institutes &
research organizations, and others. Among these, the hospitals and clinics
segment has been estimated to expand at a CAGR of 8.05% over the assessment
period. Its valuation is expected to reach USD 1,323.16 Mn over 2023.
Regional Outlook:
The global pericarditis market, by
region, has been segmented into Americas, Europe, Asia Pacific, and the Middle
East and Africa. Americas is the largest regional market for pericarditis and
is poised to touch a valuation of USD 1,122.46 Mn towards the end of 2023. The
drastic increase in the healthcare expenditure of the U.S. and Canada is
contributing significantly towards the development of the pericarditis market
in the region.
Europe, on the second spot, has been
expected to strike a relatively higher CAGR of 9.14% during the forecast
period. The access to affordable and standard medical facilities in the region
is poised to boost the future trajectory of the pericarditis market. In
addition, the efforts directed towards the development of the health systems in
the region is further anticipated to propel the expansion of the market.
Global Market for Pericarditis – Competitive
Dashboard:
Some of the prominent players operating
in the global pericarditis market are Pfizer Inc., Bayer AG, AstraZeneca Plc.,
Reckitt Benckiser Group Plc, Novartis International AG, PerkinElmer, Inc.,
FUJIFILM Holdings Corporation, Merck & Co., Inc., Sanofi, Allergan plc.,
and Johnson & Johnson Services, Inc.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/pericaditis-market-7212
About Market Research Future:
At Market Research Future (MRFR), we
enable our customers to unravel the complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients. Our market research studies by Components, Application, Logistics and
market players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology
and work process of the industry, MRFR often plans & conducts meet with the
industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
